Protective mechanism of a novel aminothiol compound on radiation-induced intestinal injury.

PURPOSE

With the development of nuclear technology and radiotherapy, the risk of radiation injury has been increasing. Therefore, it is important to find an effective radiation-protective agent. In this study, we designed and synthesized a novel compound called compound , of which the radioprotective effect and mechanism were studied.

MATERIALS AND METHODS

Before being exposed to ionizing radiation, mice were pretreated with compound . The 30-day mortality assay, hematoxylin-eosin staining, and immunohistochemistry staining assay were performed to evaluate the anti-radiation effect of the compound . TUNEL and immunofluorescence assays were conducted to study the anti-radiation mechanism of compound .

RESULTS

Compared to the IR + vehicle group, the 30-day survival rate of mice treated with 25 mg/kg of compound was significantly improved after 8 Gy total body irradiation. In the morphological study of the small intestine, we found that compound could maintain crypt-villus structures in the irradiated mice. Further immunohistochemical staining displayed that compound could improve the survival of Lgr5 cells, ki67 cells, and lysozyme cells. The results of TUNEL and immunofluorescence assays showed that compound could decrease the expression of apoptosis-related caspase-8/-9, γ-H2AX, Bax, and p53.

CONCLUSIONS

These results indicate that compound exerts its effects by maintaining structure and function of small intestine. It also reduces DNA damage, promotes crypt proliferation and differentiation. Moreover, it may enhance the anti-apoptotic ability of small intestinal tissue by inhibiting the activation of p53 and blocking the caspase cascade reaction. Compound can protect the intestinal tract from post-radiation damage, it is thus a new and effective protective agent of radiation.